 | • レポートコード：B-MOR-08457 • 出版社/出版日：Mordor Intelligence / 2018年5月1日 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（受注後2営業日） • 産業分類：医療・製薬 |
| Single User（1名様用） | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User（7名様用） | ￥666,000 (USD4,500) | ▷ お問い合わせ |
| Corporate User | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、ポイントオブケア（POC）診断の世界市場について調べ、ポイントオブケア（POC）診断の世界規模、市場動向、市場環境、製品別（血糖モニタリングキット、心血管代謝モニタリングキット、妊娠検査・不妊検査キット 、感染症検査キット、コレステロール検査ストリップ、血液検査キット、その他）分析、エンドユーザー別（病院・診療所、外来ケア、通院外科診療所、研究所、在宅ケア、その他）分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、企業の競争環境、関連企業情報などをまとめた調査レポートです。 ・イントロダクション ・エグゼクティブサマリー ・ポイントオブケア（POC）診断の世界市場インサイト ・ポイントオブケア（POC）診断の世界市場環境 ・ポイントオブケア（POC）診断の世界市場動向 ・ポイントオブケア（POC）診断の世界市場規模 ・ポイントオブケア（POC）診断の世界市場規模：製品別（血糖モニタリングキット、心血管代謝モニタリングキット、妊娠検査・不妊検査キット 、感染症検査キット、コレステロール検査ストリップ、血液検査キット、その他） ・ポイントオブケア（POC）診断の世界市場規模：エンドユーザー別（病院・診療所、外来ケア、通院外科診療所、研究所、在宅ケア、その他） ・ポイントオブケア（POC）診断の世界市場：地域別市場規模・分析 ・ポイントオブケア（POC）診断の北米市場規模・予測 ・ポイントオブケア（POC）診断のアメリカ市場規模・予測 ・ポイントオブケア（POC）診断のヨーロッパ市場規模・予測 ・ポイントオブケア（POC）診断のアジア市場規模・予測 ・ポイントオブケア（POC）診断の日本市場規模・予測 ・ポイントオブケア（POC）診断の中国市場規模・予測 ・ポイントオブケア（POC）診断のインド市場規模・予測 ・ポイントオブケア（POC）診断の韓国市場規模・予測 ・関連企業情報・競争状況 |
The Point Of Care Diagnostics Market is expected to witness a CAGR of 9.8% during the forecast period. North America accounts for the largest share of the market in 2017.
Increasing Number of Regulatory Approvals for Novel Immunoassay Techniques
Many of the new diagnostic tests and immunoassays have received the regulatory approvals, which has it made easier to conduct bedside testing or home healthcare diagnostic tests. Elecsys® HBeAg Immunoassay has been approved by the FDA, which is used to detect human Hepatitis B antigen associated with the Hepatitis B virus infection. The anti-Hepatitis C Virus Infection immunoassay test by Roche Diagnostics is one more novel product that has been approved by the FDA, in recent years. Multiple kinds of Lateral Flow Immunoassays (LFIA) are also gaining popularity, which makes it easier as well as quicker for POC testing providers to diagnose the disease. All these tests have gained popularity in a short span of time, which is leading to the growth of the market globally.
The other factors responsible for the growth of the market include, rising prevalence of chronic and infectious diseases in developing economies, private investments, and venture capital activities supporting R&D of novel products.
Product Recalls by Major Players Demotivates the New Entrants
Many of the manufacturers have been receiving complaints related to the diagnostic tests approved by the FDA, for the point of care testing. Many of the blood testing devices are also being checked by the FDA for the safety. Some of the devices show false readings, which cause severe life threatening injuries. Generally, recalling the product after it has been well placed in the market, involves high logistics costs, that cause the decline of the company profit and brand value. This ultimately affects the business and is considered a major restrain for the point of care diagnostics market.
The stringent regulatory policies and reimbursement-cuts causing pricing pressure, are also considered as restraining factors for the growth of the market.
North America Dominates the Market
The global point of care diagnostics market has been dominated by North America region, with approximately more than 42% market share of the total market in 2016. North America is growing in the point of care diagnostics market, usually due to the increasing prevalence of the diseases and favorable government regulations and initiatives, taken for the development of healthcare infrastructure. The Asia-Pacific region is also anticipated to show promising growth in the future.
Key Developments in the Market
• June 2017: Roche launches new mobile application for tablets to further improve the performance for point-of-care (POC) coordinators.
Major Players: ABBOTT, BECKMAN COULTER INC., BECTON, DICKINSON AND COMPANY, INSTRUMENTATION LABORATORY, JOHNSON & JOHNSON, NOVA BIOMEDICAL, QIAGEN, ROCHE DIAGNOSTICS LIMITED, AND SIEMENS AG, amongst others.
Reasons to Purchase the Report
• Current and future point of care diagnostics market outlook in the developed and emerging markets
• Analyzing various perspectives of the market with the help of Porter’s five forces analysis
• The segment that is expected to dominate the market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, market shares, and strategies employed by the major market players
• 3 months analyst support, along with the Market Estimate sheet (in Excel)
Customization of the Report
• This report can be customized to meet your requirements. Please connect with our analyst, who will ensure you get a report that suits your needs.
レポート目次1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter’s Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Product and Services
5.2.5 Competitive Rivalry Within the Industry
6. Drivers, Restraints, Opportunities and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Rising Prevalence of Chronic & Infectious Diseases in developing economies
6.1.2 Increasing Number of Regulatory Approvals for Novel Immunoassay Techniques
6.1.3 Private Investments and Venture Capital Activities supporting R&D of Novel Products
6.2 Market Restraints
6.2.1 Product Recalls by Major Players Demotivate New Entrants
6.2.2 Stringent Regulatory Policies are Increasing Gestation Period for Product Launches
6.2.3 Reimbursement Cuts Causing Pricing Pressure
6.3 Opportunities
6.4 Key challenges
7. Market Segmentation
7.1 By Product
7.1.1 Glucose Monitoring Kits
7.1.2 Cardio-metabolic Monitoring Kits
7.1.3 Pregnancy and Fertility Testing Kits
7.1.4 Infectious Disease Testing Kits
7.1.5 Cholesterol Test Strips
7.1.6 Hematology Testing Kits
7.1.7 Others
7.2 By End User
7.2.1 Hospitals/Critical Care Settings
7.2.2 Outpatient Healthcare Settings
7.2.3 Ambulatory Care Settings
7.2.4 Research Laboratories
7.2.5 Home Care
7.2.6 Others
7.3 By Geography
7.3.1 North America
7.3.1.1 United States
7.3.1.2 Canada
7.3.1.3 Mexico
7.3.2 Europe
7.3.2.1 France
7.3.2.2 Germany
7.3.2.3 United Kingdom
7.3.2.4 Italy
7.3.2.5 Spain
7.3.2.6 Rest of Europe
7.3.3 Asia-pacific
7.3.3.1 China
7.3.3.2 Japan
7.3.3.3 India
7.3.3.4 Australia & New Zealand
7.3.3.5 South Korea
7.3.3.6 Rest of Asia-Pacific
7.3.4 Middle east & Africa
7.3.4.1 GCC
7.3.4.2 South Africa
7.3.4.3 Rest of the Middle East & Africa
7.3.5 South America
7.3.5.1 Brazil
7.3.5.2 Argentina
7.3.5.3 Rest of South America
8. Competitive Landscape
8.1 Mergers & Acquisition Analysis
8.2 Agreements, Collaborations and Partnerships
8.3 New Products Launches
9. Key Players
9.1 Abbott
9.2 Siemens AG
9.3 Beckman Coulter Inc.
9.4 Becton, Dickinson and Company
9.5 Instrumentation Laboratory
9.6 Johnson & Johnson
9.7 Nova Biomedical
9.8 Qiagen
9.9 F. Hoffmann-La Roche Ltd
9.10 List Not Exhaustive
10. Future of the Market